References
- Korte F, Nolte S, Chichkov BN, Bauer T, Kamlage G, Waner T, Fallnich C, Welling H. Far-field and near-field material processing with femtosecond laser pulses. Appl Phys A 1999; 69: doi:10.1007/s003399900391.
- Serbin J, Bauer T, Fallnich C, Kasenbacher A, Arnold WH. Femtosecond lasers as novel tool in dental surgery. Applied Surface Sci 2002; 197: 737-40.
- Atif M, Dyer PE, Paget TA, Snelling HV, Stringer MR.Two-photon excitation studies of m-THPC photosensitizer and photodynamic activity in an epithelial cell line. Photodiagnosis Photodyn Ther 2007; 4: 106-11.
- Tandan S, Lamba AK, Faraz F, Aggarwal K, Chowdhri K. A case report of bisphosphonate related osteonecrosis of the jaw treated byphotodynamic therapy. Photodiagnosis Photodyn Ther 2019; 26: 313-5.
- American Cancer Society web page. https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/photodynamic-therapy.html [cited 2020 May 03].
- Singer A, Markoutsa E, Limayem A, Mohapatra SS. Nanobiotechnology medical applications: Overcoming challenges through innovation. The EuroBiotech J 2018; 2: 146-60.
- Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer. 2018; 103: 356-87.
- Kawczyk-Krupka A, Bugaj AM, Latos W, Zaremba K, Wawrzyniec K, Kucharzewski M, Sieron´ A. Photodynamic therapy in colorectal cancer treatment—The state of the art in preclinical research. Photodiagnosis Photodyn Ther 2015; doi:10.1016/j.pdpdt.2015.07.175.
- Bugaj AM. Targeted photodynamic therapy—a promising modality of cancer treatment. Photochem Photobiol Sci 2011; 10: 1097-109.
- Kiesslich T, Krammer B, Plaetzer K. Cellular mechanisms and prospective applications of hypericin in photodynamic therapy. Curr Med Chem 2006; 13: 2189-204.
- Kars MD, Kara R, Gündoğdu Y, Kepceoğlu A, Kılıç HŞ. Femtosecond laser induced photodynamic therapy on 5-ALA treated SKMEL-30 cells: an efficient theranostic strategy to combat melanoma. Biomed Pharmacother. 2014, 68: 657-62.
- Kars G, Ceylan A. Biohydrogen and 5-aminolevulinic acid production from waste barley by Rhodobacter sphaeroides O.U.001 in a biorefinery concept. Int J Hydrogen Energ 2013; 38: 5573-9.
- Iinuma S, Farshi SS, Ortel B, Hasan T. A Mechanistic Study of Cellular Photodestruction with 5-Aminolevulinic Acid-Induced Porphyrin. Br J Cancer 1994; 70: 21-8.
- Lang K, Bolsen K, Stahl W, Ruzicka T, Sies H, Lehmann P, Fritsch C. The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin. J Photochem Photobiol B 2001; 65: 29-34.
- Li Y, Wang P, Zhao P, Zhu S, Wang X, Liu Q. Apoptosis induced by sonodynamic treatment by protoporphyrin IX on MDA-MB-231 cells. Ultrasonics 2012; 52: 490-6.
- Taylor EL, Brown SB. The advantages of aminolevulinic acid photodynamic therapy in dermatology. J Dermatolog Treat 2002; 13: 3-11.
- Ackroyd R, Kelty C, Brown N, Reed M. The History of Photodetection and Photodynamic Therapy. Photochem Photobiol 2001; 74: 656-69.
- Kars G, Alparslan Ü. Valorization of sugar beet molasses for the production of biohydrogen and 5-aminolevulinic acid by Rhodobacter sphaeroides O.U.001 in a biorefinery concept. Int J Hydrogen Energ 2013; 38: 14488-94.
- Krammer B, Uberriegler K. In-vitro investigation of ALA-induced protoporphyrin IX. J Photochem Photobiol B 1996; 36: 121-6.
- Schmitz L, Novak B, Hoeh AK, Luebbert H, Dirschka T. Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin. Photodiagnosis Photodyn Ther 2016; 14: 40-6.
- Palasuberniam P, Yang X, Kraus D, Jones P, Myers KA, Chen B. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy. Sci Rep 2015; doi:10.1038/srep13298.
- Murtagh J. Femtosecond Laser-Assisted Cataract Surgery (FLACS): Issues in emerging health technologies. Ottawa: Canadian Agency for Drugs and Technologies in Health. 2014; pp 126.
- Bogoeva V, Siksjø M, Saeterbø KG, Melo TB, Bjorkoy A, Lindgren M, Gederaas OA. Ruthenium porphyrin-induced photodamage in bladder cancer cells. Photodiagnosis Photodyn Ther 2016; doi: 10.1016/j.pdpdt.2016.01.012.
- Qiao L, Mei Z, Yang Z, Li X, Cai H, Liu W. ALA-PDT inhibits proliferation and promotes apoptosis of SCC cells through STAT3 Signal Pathway. Photodiagnosis Photodyn Ther 2016; doi: 10.1016/j.pdpdt.2016.01.008.
- Di Venosa G, Batlle A, Fukuda H, Macrobert A, Casas A. Distribution of 5-aminolevulinic acid derivatives and induced porphyrin kinetics in mice tissues. Cancer Chemother Pharmacol 2006; 58: 478-86.
- Wan MT, Lin JY. Current evidence and applications of photodynamic therapy in dermatology. Clin Cosmet Investig Dermatol. 2014; 21, 7: 145-63.
- Yang X, Palasuberniam P, Kraus D, Chen B. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement. Int J Mol Sci. 2015; 16: 25865-80.
- Barcessat AR, Huang I, Rosin FP, dos Santos Pinto D Jr, Maria Zezell D, Correa L. Effect of topical 5-ALA mediated photodynamic therapy on proliferation index of keratinocytes in 4-NQO-induced potentially malignant oral lesions. J Photochem Photobiol B 2013; 126: 33-41.
- Hammer DX, Thomas R J, Noojin GD, Rockwell BA, Kennedy PK, Roach WP. Experimental investigation of ultrashort pulse laser-induced breakdown thresholds in aqueous media. IEEE J Quant Electron 1996; 32: 670-8.
- Hashmi JT, Huang YY, Sharma SK, Kurup DB, De Taboada L, Carroll JD, Hamblin MR. Effect of pulsing in low-level light therapy. Lasers Surg Med 2010; 42: 450-66.